Globus Medical (GMED) Ratios
Globus Medical Ratios
MX:GMED's free cash flow for Q2 2026 was $176.57M. For the 2026 fiscal year, MX:GMED's free cash flow was decreased by $-33.17M and operating cash flow was $209.74M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 |
| Quick Ratio | 2.74 | 1.77 | 2.72 | 4.30 | 4.48 |
| Cash Ratio | 1.06 | 0.92 | 1.19 | 0.95 | 1.38 |
| Solvency Ratio | 1.12 | 0.33 | 0.25 | 1.12 | 1.01 |
| Operating Cash Flow Ratio | 1.51 | 0.61 | 0.62 | 1.12 | 1.97 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 1.17 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.40B | $ 1.10B | $ 827.25M | $ 753.59M | $ 648.64M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.10 | 0.10 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.03 | 0.13 | 0.13 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.03 | 0.11 | 0.12 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.09 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.16 | 1.26 | 1.27 | 1.12 | 1.12 |
| Debt Service Coverage Ratio | 0.00 | 1.02 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 39.63 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.04 | 0.07 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.88 | 3.99 | 4.60 | 0.06 | 0.00 |
| Net Debt to EBITDA | -0.46 | -0.52 | 0.15 | -0.47 | -0.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.41% | 58.90% | 65.05% | 74.22% | 75.03% |
| EBIT Margin | 20.75% | 8.72% | 12.87% | 23.10% | 20.34% |
| EBITDA Margin | 30.17% | 18.80% | 22.10% | 29.77% | 27.63% |
| Operating Profit Margin | 16.33% | 6.59% | 8.49% | 22.29% | 17.95% |
| Pretax Profit Margin | 20.75% | 4.79% | 10.54% | 23.76% | 18.83% |
| Net Profit Margin | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% |
| Continuous Operations Profit Margin | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% |
| Net Income Per EBT | 88.19% | 85.31% | 74.29% | 78.25% | 82.70% |
| EBT Per EBIT | 127.12% | 72.73% | 124.22% | 106.61% | 104.92% |
| Return on Assets (ROA) | 10.14% | 1.96% | 2.42% | 9.16% | 7.62% |
| Return on Equity (ROE) | 11.76% | 2.47% | 3.07% | 10.30% | 8.57% |
| Return on Capital Employed (ROCE) | 9.99% | 3.78% | 2.84% | 11.89% | 9.46% |
| Return on Invested Capital (ROIC) | 8.78% | 2.92% | 2.10% | 9.29% | 7.83% |
| Return on Tangible Assets | 17.23% | 3.41% | 4.51% | 10.48% | 8.73% |
| Earnings Yield | 4.56% | 0.92% | 2.04% | 2.55% | 2.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.95 | 4.36 | 3.11 | 4.71 | 5.78 |
| Payables Turnover | 9.69 | 13.78 | 9.67 | 7.31 | 10.90 |
| Inventory Turnover | 1.26 | 1.57 | 0.65 | 0.88 | 1.01 |
| Fixed Asset Turnover | 4.68 | 4.12 | 2.42 | 4.20 | 4.33 |
| Asset Turnover | 0.55 | 0.48 | 0.31 | 0.49 | 0.49 |
| Working Capital Turnover Ratio | 1.99 | 1.77 | 1.34 | 1.32 | 1.34 |
| Cash Conversion Cycle | 344.04 | 289.68 | 644.48 | 441.38 | 391.22 |
| Days of Sales Outstanding | 92.36 | 83.79 | 117.49 | 77.55 | 63.11 |
| Days of Inventory Outstanding | 289.35 | 232.38 | 564.73 | 413.79 | 361.61 |
| Days of Payables Outstanding | 37.67 | 26.48 | 37.73 | 49.96 | 33.50 |
| Operating Cycle | 381.71 | 316.16 | 682.22 | 491.34 | 424.72 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.57 | 3.84 | 2.15 | 1.78 | 2.74 |
| Free Cash Flow Per Share | 4.36 | 2.99 | 1.46 | 1.04 | 2.18 |
| Dividend Paid and CapEx Coverage Ratio | 4.58 | 4.51 | 3.11 | 2.41 | 4.86 |
| Capital Expenditure Coverage Ratio | 4.58 | 4.51 | 3.11 | 2.41 | 4.86 |
| Operating Cash Flow Coverage Ratio | 6.35 | 0.97 | 0.47 | 29.69 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.21 | 0.16 | 0.17 | 0.29 |
| Free Cash Flow Yield | 4.99% | 3.61% | 2.74% | 1.40% | 3.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.94 | 108.83 | 49.05 | 39.24 | 48.75 |
| Price-to-Sales (P/S) Ratio | 4.02 | 4.46 | 3.84 | 7.30 | 7.59 |
| Price-to-Book (P/B) Ratio | 2.58 | 2.69 | 1.51 | 4.04 | 4.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.04 | 27.70 | 36.47 | 71.46 | 33.15 |
| Price-to-Operating Cash Flow Ratio | 15.66 | 21.56 | 24.75 | 41.81 | 26.33 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -3.59 | -1.16 | 1.42 | 1.15 |
| Enterprise Value Multiple | 12.85 | 23.18 | 17.54 | 24.03 | 26.74 |
| Enterprise Value | 11.39B | 10.98B | 6.08B | 7.32B | 7.08B |
| EV to EBITDA | 12.85 | 23.18 | 17.54 | 24.03 | 26.74 |
| EV to Sales | 3.88 | 4.36 | 3.88 | 7.15 | 7.39 |
| EV to Free Cash Flow | 19.35 | 27.09 | 36.80 | 70.08 | 32.27 |
| EV to Operating Cash Flow | 15.12 | 21.09 | 24.97 | 41.00 | 25.63 |
| Tangible Book Value Per Share | 17.71 | 14.37 | 14.49 | 15.78 | 14.82 |
| Shareholders’ Equity Per Share | 33.84 | 30.78 | 35.35 | 18.38 | 17.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.15 | 0.26 | 0.22 | 0.17 |
| Revenue Per Share | 21.75 | 18.56 | 13.87 | 10.18 | 9.51 |
| Net Income Per Share | 3.98 | 0.76 | 1.09 | 1.89 | 1.48 |
| Tax Burden | 0.88 | 0.85 | 0.74 | 0.78 | 0.83 |
| Interest Burden | 1.00 | 0.55 | 0.82 | 1.03 | 0.93 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.08 | 0.07 | 0.10 |
| SG&A to Revenue | 0.45 | 0.39 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| Income Quality | 1.40 | 5.06 | 1.98 | 0.94 | 1.85 |
Currency in USD